Full Year Results 

Spirax-Sarco justifies strong support

Spirax-Sarco justifies strong support

Management can only do so much in the face of a deteriorating macro outlook, so Spirax-Sarco’s (SPX) impressive full-year performance was tempered by a caveat that industrial production growth had slowed throughout the year and was likely to drop further in 2019.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe
Subscribe to Investors Chronicle

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now